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THE CORRELATES OF THE SYNDROME OF 
DEPRESSION IN SCHIZOPHRENIA 
ANNATHARYAN, K. KURUVILLA 
A depressive syndrome as identified by subjectively volunteered dysphoria occurred in 17.4% of a 
group of 45 /ASM III-R schizophrenics, studied initially in a medication free state. Among the 24 patients 
who could be followed up for six months, another 25% developed depressive symptoms while on 
treatment. Mild depressive syndromes occurred more frequently in older patients, in association with 
retained insiglu and lower negative symptoms scores. While depressive symptoms occurred both in the 
medicated and unmedicated state, depressed medicated schizophrenics differed from non-depressed 
medicated schizophrenics on variables of total medication dosage, presence of extrapyramidal 
symptoms and insight. 
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INTRODUCTION 
Depressive features occurring in schizophrenia 
have long been documented (Bleuler, 1950; 
Johnson, 1<)81; Roy, 1983; Siris, 1991). The admix-
ture has been noted in the prodromal stage, during 
the active psychotic state (Johnson, 1981) and also 
in the post psychotic period (McGlashan, 1976). 
Etiological factors implicated have ranged from the 
psychological stress resulting from the experience 
of a chronic psychosis, to an iatrogenic (De Alarcon 
& Carney, 1969) or extrapyramidal syndrome re-
lated phenomenon (Van Puiten, 1978). It has also 
been reported to be difficult to distinguish from the 
negative symptoms of schizophrenia (Knights & 
Hirsch, 1981). 
Overlooking a wide variability of methodology, 
a rough estimate of prevalence from previous studies 
would be between 25% and 50% (Shanfield et al, 
1970; Mandel et al, 1982; Siris, 1991). The impor-
tance of the depressive syndrome in predicting 
suicide and chronicity in schizophrenia has been 
well recognized (Roy, 1986). 
This study was conducted to estimate the 
prevalence of the depressive syndrome in a group of 
non-institutionalized, actively psychotic 
schizophrenic patients and to study the clinical and 
treatment correlates of depressive symptoms. 
MATERIAL AND METHODS 
All patients between eighteen and fifty years of 
age, who attended the Psychiatry clinic of a general 
hospital for a period of" one year, who qualified for 
a DSM Ill-R diagnosis of schizophrenia on the basis 
of clinical interview, and who had been off all antip-
sychotic medication for a minimum of one month 
previously, were studied. 
Diagnosis was made by concurrence between 
two psychiatrists not involved in the study. There-
upon, the first author interviewed patient and rela-
tive separately, corroborating diagnosis and 
recording sociodemographic variables, duration of 
illness and family history of depression and 
schizophrenia. Life stresses that could be understood 
to have provoked depression were enquired for, on 
the lines of Gurmeet Singh's life event scale (Gur-
meet Singh, 1981). 
Positive and negative symptoms were scored 
using the Scale of Assessment of Positive Symptoms 
(SAPS) (Andreasen, 1984), and the Scale of Assess-
ment of Negative Symptoms (SANS) (Andreasen, 
1982). Insight was scored on a six point scale 
(Kaplan & Sadock, 1989). Extrapyramidal 
symptoms were scored on the Simpson Angus Ex-
trapyramidal Side Effect Scale (Simpson and Angus, 
1970). 
Depression was defined as a positive score on 
item one of the Hamiltpn Depressive Scale (Hamil-
ton, 1960). In addition, item 2: guilt, 3: suicide, 7: 
work and interests, 8: retardation, 9: helplessness, 
24: worthlessness, were also scored, on the basis that 
these represented the psychological symptoms of 
depression. Items 4 to 6,11 to 17 and 19 to 2!, being 
the somatic accompaniments of depression were 
excluded. This was done in order to specifically 
identify the psychic components of depression with 
as little overlap as possible, with cither the side 
effects of medication or the non-specific 
symptomatology of any psychotic illness. This 
method is similar to that of Becker et al (1985) in 
identifying target symptoms of depression, Depres-
sive symptoms were required to have been present 
for at least one week to be scored, thus excluding 
transient mood changes. 
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were divided into two groups: a] present, if the score 
was one or more than one and b] absent if the score 
was zero. Insight during the treatment period was 
scored as present, if insight was gained in any of the 
months of follow-up. Insight before treatment was 
scored on the basis of the level of insight on the first 
visit alone. 
Similarly, the global ratings of affective flatten-
ing, alogia; avolition and apathy, anhedonia-
asociality and inattention were added up to give a 
total SANS score. Global rating on hallucinations, 
delusions, bizarre behavior and positive formal 
thought disorder were converted into their 
chlorpromazine equivalents and the average dose, 
over the total follow-up period were calculated. 
Statistical evaluation was done using the t-test, 
Fishers's exact test of probability and chi-square test 
of significance wherever applicable. 
RESULTS 
The population under study consisted of 46 un-
medicated patients with schizophrenia. Age ranged 
from 18 to 54 years, with a mean of 31.4 years. There 
was a slight male preponderance, with 26 males and 
20 females. Of the subjects, 25 were married and 21 
were unmarried; 14 were illiterate and 32 had com-
pleted 5 years or more of schooling. 29 were either 
unemployed or unskilled laborers. The duration of 
illness ranged from 0.6 to 20 years with a mean of 5 
years. A family history of depression was present in 
four patients. The global score on SAPS ranged from 
3 to 24 with a mean of 8.5 (SD 2.8) while that on 
SANS ranged from 0.24 with a mean of 3.7 (SD 5.4). 
All patients were in the active stage of disease 
with an admixture of positive and negative 
symptoms. None had experienced triggering life 
stresses. There was a drop out rate of 48% after the 
first visit. Twenty four patients could be followed up 
for periods ranging from 1 to 10 months. 
DEPRESSIVE SYMPTOMS 
a) Prevalence: Eight out of forty six patients 
(17.4%) were depressed in the unmedicated state. 
Among the 24 patients who were available for fol-
low-up 6 (25%) developed depressive symptoms 
anew while on medication. 
Table 1 
Hamilton depression rating scale item score: medicated and unmedicated groups of depressed patients 
HDRS.  1 
UNMEDICATED 
PATIENTS 
Pt.No.1 
2 
3 
4 
5 
6 
7 
8 
Total no.of 
patients with 
each item 
MEDICATED 
PATIENTS 
PtNo. 9 
10 
11 
12 
13 
14 
Total no.of 
patients with 
each item 
2 
1 
1 
3 
2 
1 
1 
2 
8 
2 
2 
3 
3 
3 
2 
6 
2 
0 
0 
0 
0 
0 
0 
0 
4 
1 
0 
0 
0 
4 
0 
0 
1 
3 
2 
0 
2 
0 
2 
1 
2 
0 
S 
3 
1 
1 
0 
2 
4 
5 
7 
4 
0 
3 
0 
4 
3 
4 
3 
6 
4 
4 
3 
3 
2 
4 
6 
8 
2 
0 
1 
0 
2 
2 
0 
0 
4 
0 
0 
1 
0 
0 
2 
2 
9 
0 
0 
0 
0 
0 
0 
2 
4 
2 
2 
0 
1 
2 
0 
1 
4 
10 
3 
0 
0 
0 
3 
0 
2 
0 
3 
3 
1 
3 
0 
3 
2 
5 
18 
1 
0 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
0 
1 
0 
1 
22 
1 
0 
0 
0 
0 
0 
0 
1 
2 . 
1 
0 
1 
2 
0 
0 
3 
23 
2 
0 
0 
0 
0 
0 
0 
0 
1 
1 
0 
1 
3 
1 
0 
4 
24 
0 
0 
0 
0 
0 
2 
0 
0 
1 
0 
0 
0 
0 
0 
1 
1 
Total number of Items 
scored by each patient 
8 
1 
4 
1 
5 
S 
S 
S 
7 
4 
8 
6 
6 
7 
Total score on 
all 11 items 
17 
1 
7 
3 
13 
9 
11 
14 
16 
8 
14 
17 
12 
16 
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b) Intensity and quality of depression: The inten-
sity of the depressive syndrom e was not pronounced, 
as reflected by the fact that the total HDRS score on 
eleven items ranged between 1 and 17 with a mean 
of 11 out of a possible total of 42. The maximum 
score on item one of HDRS i.e. depressed mood, was 
3 (moderate level). 
Table 1 shows the scores on each of the chosen 
items on the HDRS, for each of 14 depressed 
patients. The items which received a maximum 
score most frequently is 'loss of work interest'. 
Feelings of hopelessness, worthlessness and help-
lessness have rarely been prominent. Severesuicidal 
rumination was present in only one patient. Diurnal 
variation of symptoms was a rare feature. No patient 
scored all eleven items present. 
Perusal of the HDRS scores of all 14 depressed 
patients reveals very little scatter between score on 
individual patients. It is therefore unlikely that there 
is a difference in the quality or intensity of depres-
sion in the medicated versus the unmedicated state. 
COMPARISON OF DEPRESSED AND 
NON-DEPRESSED SCHIZOPHRENICS 
a) Demographic variables: Except for sig-
nificantly greater number of older patients in the 
depressed category (Chi square 0.05), the groups did 
not differ on demographic variables. 
b) Clinical Variables: Depressed and non-
depressed patients did not differ in chronicity of 
illness, frequency of depressed relatives or mag-
nitude of positive symptoms. However, the 
depressed patients appeared to show less negative 
symptomatology than the non-depressed patients. In 
other words, negative symptoms were distinguish-
able from depression (Table 2). 
Depression and insight were closely associated, 
both in those depressed patients who were on treat-
ment as well as in those in the unmedicated state. 
Whereas in depressed unmedicated patients 50% of 
patient had insight, in non-depressed unmedicated 
patients none had insight. 83% of the depressed 
medicated patients and 41.3% of non-depressed 
medicated patients had insight. Since the presence 
of any degree of insight amounted to a positive 
score, the number of patients who count as having 
retained insight could have become high. However, 
in view of theories linking depression in 
schizophrenia with a realisation of the illness, the 
preponderance of patients with insight in the 
depressed category cannot be overlooked. 
Table 2 
Clinical characteristics of depressed vs non-depressed 
schizophrenic patients 
A. Duration of illness* 
0Ti») 
Mean(±SD) 
Range 
Fishers exact test: NS 
& Family history of 
depression 
Present 
Absent 
Fishers exact test NS 
C.SAPS+score 
Mean (± SO) 
Range 
Students t test: NS 
D. SANS++ score 
Mean (± SO) 
Range 
Depressed 
(n«14) 
5.4 (± 5.1, 
1-17 
Depressed 
(p-14) 
2 
12 
Depressed 
(n=14) 
9.1 (±2.8) 
5-14 
UOpfOSSwO 
(n-14) 
11.2 (±5.0) 
0-23 
Students t test t=2.41;p<0.05 
Non -depressed 
(n=32) 
4.8 (± 4.2) 
0.5-20 
Non-depressed 
(n=32) 
2 
30 
Non-depressed 
(n=32) 
8.8 (±3.9) 
3-24 
Non-depressed 
(n=32) 
15.1 (±5.1) 
6-24 
* Number of years from onset of illness of assessment; + 
Scale for Assessment of Positive Symptoms: global score at 
intake; ++ Scale for Assessment of Negative Symptoms: 
global score at intake. 
c) Extrapyramidal Symptoms, medication and 
depression: Among patients who received treat-
ment, extrapyramidal symptoms were found in 50% 
of those who developed depression, and only in 16% 
of those who were not depressed. Antipsychotic 
medication in a dose of 600 mg. of chlorpromazine 
equivalents or more per day was being prescribed in 
5 out of 6 depressed patients, but only in two out of 
twelve in the non-depressed category. 
Table 3 shows that both the frequency of ad-
ministration of antiparkinsonian medication as well 
as the average dose of medication given were greater 
in the depressed patients. Propranolol, used for con-
trol of akathisia has been given only to the depressed 
category. In all cases it was started after the develop-
ment of depression. No patient had been put on 
antidepressants. 
d) Attempted suicide: In three out of fourteen 
depressed patients, a history of attempted suicide 
was elicited, whereas none of the non-depressed 
category had done so. 
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Table 3 
Average medication (milligrams per day) for extrapyramidal symptoms in depressed and non-depressed 
schizophrenic patients 
PatNo Procyclidine 
1 5 
2 
3 
4 
5 15 
6 12 
Average dose of 
Depressed group 
Non-depressed group 
Depressed 
Trihexiphenidyl 
. 
6 
4 
6 
. 
. 
Procyclidine or 
10.6 
5.0 
DISCUSSION 
Propranolol 
. 
50 
20 
40 
. 
• 
Trihexiphenidyl or 
5.3 
4 
Patient No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Propranolol 
36.7 mg 
Omg 
Non-depressed 
Procyclidine 
0 
2.5 
7.5 
0 
0 
0 
0 
0 
0 
0 
0 
0 
developed depression in 
Trihexiphenidyl 
0 
0 
0 
0 
4 
4 
4 
4 
4 
4 
0 
0 
Propranolol 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
the unmedicated state and 
Depressive symptoms have been studied in a 
population of schizophrenic patients diagnosed by 
operationally defined criteria and uncontaminated 
by schizoaffective disorder or psychotic depression. 
Rarely has it been highlighted that in unmedicated 
schizophrenics the occurrence of depressive features 
is in the order of 17.4%. In the study by Raju (1986), 
34% of first contact schizophrenics had depressive 
symptoms. This higher rate could be due to the fact 
that, for diagnosing depression, either "one or more 
distinct period of dysphoric mood" or "pervasive 
loss of interest or pleasure" were sufficient. Since 
the second item may be present purely as part of the 
negative symptoms of schizophrenia, it is possible 
that there may have been some degree of overlap. 
The occurrence of depressive features in unmedi-
cated schizophrenia suggests causes other than an-
tipsychotic induced syndromes or the "revealed 
depression" of Knights and Hirsch (1981). Since the 
insight is fairly prominently associated with depres-
sive symptoms both in the medicated as well as 
unmedicated state the "reactive" etiology remains a 
strong possibility. Tentative support could also be 
drawn for the concept of akinetic depression, given 
the association between high dose antipsychotics, 
extrapyramidal syndromes and the occurrence of 
depression in schizophrenia. The inference that 
there seems to be more than one cause for the depres-
sion in the population under study is amply sup-
ported by the fact that one group of patients 
group developed it while on treatment. The precise 
degree to which each of the above mentioned factors 
contribute to the causation of depression in 
schizophrenia can be determined only by studying a 
larger population with a longer follow-up. 
A striking feature which stands out in this study 
is the mild nature of depression. This is better ap-
preciated by comparing the frequency of occurrence 
of HDRS item chosen for study with the findings 
from a study by Hamilton (1989) using the HDRS 
on a group of melancholies (Table 4). 
Table 4 
Frequency of MORS symptoms 
HDRS. Items 
Kern No 
1 Depressed mood 
2 Quilt 
3 Suicidal thoughts 
7 Work and interests 
8 Retardation 
9 Agitation 
10 Anxiety (Psychic) 
18 Diurnal variation 
Worse mornings 
Worse evenings 
22 Helplessness 
23 Hopelessness 
24 Worthlessness 
N 
14 
3 
8 
13 
8 
7 
8 
2 
0 
5 
6 
3 
Depressed 
Schizophrenics 
% 
100 
21 
56 
91 
56 
50 
56 
14 
-
35 
42 
21 
Melancholies* 
% 
100 
72.1 
81.2 
97.4 
68.1 
47.9 
99.2 
63.4 
. 
NA 
NA 
NA 
* Percent score is the average of the score on HDRS of mate 
and female melancholies (Hamilton, 1989); NA - not 
available.. 
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Therefore, when schizoaffective disorder and 
psychotic depression are excluded by applying strict 
criteria, the depressive symptoms that occur in 
schizophrenia are mild and of heterogenous etiol-
ogy-
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